PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, c/ Manuel de Falla 1, 28222, Madrid, Spain.\', \'Hemotherapy & Apheresis Units, Hematology and Hemotherapy Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.\', \'Clinical Pharmacology Department, Hospital Universitario Puerta de Hierro Majadahonda, Instituto de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, c/ Manuel de Falla 1, 28222, Madrid, Spain. Aranzazu.sancho@salud.madrid.org.\', \'Internal Medicine Department, Infectious diseases unit, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.\', \'Clinical Pharmacology Department, Hospital Clínic Barcelona, Medical Statistics core facility - IDIBAPS, Barcelona, Spain.\', \'Pneumology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.\', \'IIS Puerta de Hierro - Segovia de Arana, Madrid, Spain.\', \'Flu and Respiratory Virus Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.\', \'Hematology and Hemotherapy Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1186/s13063-020-05011-9
?:doi
?:hasPublicationType
?:journal
  • Trials
is ?:pmid of
?:pmid
?:pmid
  • 33472681
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.291
?:rankingScore_hIndex
  • 57
is ?:relation_isRelatedTo_publication of
?:title
  • Evaluation of convalescent plasma versus standard of care for the treatment of COVID-19 in hospitalized patients: study protocol for a phase 2 randomized, open-label, controlled, multicenter trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all